Cercato, C.
Fonseca, F. A.
Funding for this research was provided by:
Novo Nordisk FarmacĂȘutica do Brasil LTDA
Article History
Received: 25 March 2019
Accepted: 17 July 2019
First Online: 28 August 2019
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: FF has served as steering committee member for Novartis and Astra Zeneca, and reports having received research grants, lecture fees, and consulting fees from AstraZeneca, Bayer, Sanofi-Aventis, Novo Nordisk, Novartis, Takeda, Amgen, Biolab, Ache, EMS, and Merck. CC has served as advisory board for Eurofarma and Novo NordisK, and reports having received research grants from AstraZeneca, Sanofi-Aventis, Novo Nordisk, Eurofarma, Fractyl, Lilly, Boehringer Ingelheim, and Abbvie. The authors declare that they have no competing interests.